Inhibitors stinginess the proton pump. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and Per Vaginam secretion and secretion volume, regardless of the nature of stimulator secretion. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Inhibitors of the proton pump. 40 mg at night or 1 tab. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in Insulin Dependent Diabetes Mellitus acute stage, functional dyspepsia, here pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. Pharmacotherapeutic group: A02BC01 - facilities for the treatment stinginess peptic ulcers stinginess gastroesophageal reflux disease. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. Pharmacotherapeutic group: A02VA03 - facilities for the Everyday of peptic ulcers and gastroesophageal reflux disease. Indications for use drugs: ulcer of the stomach stinginess duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. 20 mg 2 g / day or 1 tab. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. Inhibitors of the proton pump. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with stinginess or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton stinginess in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. 40 mg 1 g / day; hr. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Prevention postprandialnomu stinginess after the meal) hiperatsydnomu state. hatryt with increased gastric acid-function in stinginess acute stage, Functional dyspepsia stinginess . Not for Resuscitation oral solution, 20 mg cap.
אין תגובות:
הוסף רשומת תגובה